hope for future therapeutic development is highest in rheumatoid arthritis with the second-line agents ( e.g . gold , penicillamine ) , as unravelling their mechanism of action may lead to the design of more effective and less toxic medications .
C0003873
rheumatoid arthritis
C0030817
penicillamine